Non-melanoma skin cancer (NMSC), including basal and squamous cell carcinoma (BCC and SCC), represents the most common malignancy.
Objective
To provide guidance to Canadian health care practitioners regarding primary prevention of NMSC.
Methods
Structured literature searches were conducted, using search terms including prevention, sunscreen, and sun prevention factor. All recommendations concern guidance that physicians should regularly discuss with their patients to help establish photoprotection habits. The GRADE system was used to assign strength to each recommendation.
Results
Ultraviolet exposure is the major modifiable risk factor for NMSC. Aspects of photoprotection, including effective sunscreen use and avoidance of both the midday sun and artificial tanning, are discussed. Several widespread misunderstandings that undermine responsible public health measures related to sun safety are addressed.
Conclusions
Photoprotection represents both an individual priority and a public health imperative. By providing accurate information during routine patient visits, physicians reinforce the need for ongoing skin cancer prevention.
RoelandtsR.History of human photobiology. In: LimH, HönigsmannH, HawkJ, eds. Photodermatology.New York, NY: Informa Healthcare USA;2007.
2.
GallagherRP, HillGB, BajdikCD.Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma.Arch Dermatol.1995; 131(2): 164–169.
3.
KrickerA, ArmstrongBK, EnglishDR, HeenanPJ.Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia.Int J Cancer.1995; 60(4): 489–494.
4.
NaldiL, DiLandroA, D'AvanzoB, ParazziniF.Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study.J Am Acad Dermatol.2000; 42(3): 446–452.
5.
RossoS, ZanettiR, MartinezC.The multicentre south European study ‘Helios’. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin.Br J Cancer.1996; 73(11): 1447–1454.
6.
GallagherRP, LeeTK.Adverse effects of ultraviolet radiation: a brief review.Prog Biophys Mol Biol.2006; 92(1): 119–131.
7.
EnglishDR, ArmstrongBK, KrickerA.Case-control study of sun exposure and squamous cell carcinoma of the skin.Int J Cancer.1998; 77(3): 347–353.
8.
GodarDE, UrbachF, GasparroFP, van der LeunJC.UV doses of young adults.Photochem Photobiol.2003; 77(4): 453–457.
9.
LinosE, KeiserE, KanzlerM.Sun protective behaviors and vitamin D levels in the US population: NHANES 20032006.Cancer Causes Control.2012; 23(1): 133–140.
10.
DarlingtonS, WilliamsG, NealeR.A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses.Arch Dermatol.2003; 139(4): 451–455.
11.
GreenA, WilliamsG, NealeR.Daily sunscreen application and betacarotene supplementation in prevention of basalcell and squamous-cell carcinomas of the skin: a randomised controlled trial.Lancet.1999; 354(9180): 723–729.
12.
van der PolsJC, WilliamsGM, PandeyaN.Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.Cancer Epidemiol Biomarkers Prev.2006; 15(12): 2546–2548.
13.
ZwaldFO, BrownM.Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.J Am Acad Dermatol.2011; 65(2): 253–261.
14.
LindelofB, SigurgeirssonB, GabelH, SternRS.Incidence of skin cancer in 5356 patients following organ transplantation.Br J Dermatol.2000; 143(3): 513–519.
15.
StockflethE, UlrichC, MeyerT, ChristophersE.Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.Recent Results Cancer Res.2002; 160: 251–258.
16.
UlrichC, JurgensenJS, DegenA.Prevention of nonmelanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.Br J Dermatol.2009; 161 (suppl 3): 78–84.
17.
EuvrardS, KanitakisJ, DecullierE.Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.Transplantation.2006; 81(8): 1093–1100.
18.
EnglishDR, ArmstrongBK, KrickerA.Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study.Int J Cancer.1998; 76(5): 628–634.
19.
KrickerA, ArmstrongBK, EnglishDR, HeenanPJ.Pigmentary and cutaneous risk factors for nonmelanocytic skin cancer—a case-control study.Int J Cancer.1991; 48(5): 650–662.
20.
GlosterHMJr, NealK.Skin cancer in skin of color.J Am Acad Dermatol.2006; 55(5): 741–760.
21.
HalderRM, BangKM.Skin cancer in blacks in the United States.Dermatol Clin.1988; 6(3): 397–405.
SheehanJM, PottenCS, YoungAR.Tanning in human skin types II and III offers modest photoprotection against erythema.Photochem Photobiol.1998; 68(4): 588–592.
24.
MiyamuraY, CoelhoSG, SchlenzK.The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin.Pigment Cell Melanoma Res.2011; 24(1): 136–147.
25.
NorvalM, HallidayGM.The consequences of UV-induced immunosuppression for human health.Photochem Photobiol.2011; 87(5): 965–977.
KambayashiH, OdakeY, TakadaK.Involvement of changes in stratum corneum keratin in wrinkle formation by chronic ultraviolet irradiation in hairless mice.Exp Dermatol.2003; 12 (suppl 2): 22–27.
33.
AgarNS, HallidayGM, BarnetsonRS.The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis.Proc Natl Acad Sci USA.2004; 101(14): 4954–4959.
34.
FourtanierA, MoyalD, SeiteS.Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.Photodermatol Photoimmunol Photomed.2008; 24(4): 164–174.
35.
HallidayGM, ByrneSN, DamianDL.Ultraviolet A radiation: its role in immunosuppression and carcinogenesis.Semin Cutan Med Surg.2011; 30(4): 214–221.
36.
YoungAR, ChadwickCA, HarrisonGI.The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema.J Invest Dermatol.1998; 111(6): 982–988.
37.
ZhangX, RosensteinBS, WangY.Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells.Photochem Photobiol.1997; 65(1): 119–124.
38.
BolshakovS, WalkerCM, StromSS.p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.Clin Cancer Res.2003; 9(1): 228–234.
39.
BrashDE, RudolphJA, SimonJA.A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.Proc Natl Acad Sci USA.1991; 88(22): 10124–10128.
40.
ZieglerA, LeffellDJ, KunalaS.Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.Proc Natl Acad Sci USA.1993; 90(9): 4216–4220.
41.
KanjilalS, StromSS, ClaymanGL.p53 mutations in non-melanoma skin cancer of the head and neck: molecular evidence for field cancerization.Cancer Res.1995; 55(16): 3604–3609.
42.
NelsonMA, EinspahrJG, AlbertsDS.Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.Cancer Lett.1994; 85(1): 23–29.
43.
ZieglerA, JonasonAS, LeffellDJ.Sunburn and p53 in the onset of skin cancer.Nature.1994; 372(6508): 773–776.
Centers for Disease Control Prevention.Sunburn and sun protective behaviors among adults aged 18-29 years—United States, 2000-2010.MMWR Morb Mortal Wkly Rep.2012; 61(18): 317–322.
46.
HillD, DixonH.Promoting sun protection in children: rationale and challenges.Health Educ Behav.1999; 26(3): 409–417.
47.
CoglianoVJ, BaanR, StraifK.Preventable exposures associated with human cancers.J Natl Cancer Inst.2011; 103(24): 1827–1839.
48.
TierneyP, FergusonJ, IbbotsonS.Nine out of 10 sunbeds in England emit ultraviolet radiation levels that exceed current safety limits.Br J Dermatol.2013; 168: 602–608.
49.
WrightAL, HartGC, KernohanE, TwentymanG.Survey of the variation in ultraviolet outputs from ultraviolet A sunbeds in Bradford.Photodermatol Photoimmunol Photomed.1996; 12(1): 12–16.
50.
GerberB, MathysP, MoserM.Ultraviolet emission spectra of sunbeds.Photochem Photobiol.2002; 76(6): 664–668.
51.
National Toxicology Program.Report on Carcinogens.Washington, DC: US Department of Health and Human Services;2011.
52.
KaragasMR, StannardVA, MottLA.Use of tanning devices and risk of basal cell and squamous cell skin cancers.J Natl Cancer Inst.2002; 94(3): 224–226.
53.
WehnerMR, ShiveML, ChrenMM.Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis.BMJ.2012; 345: e5909.
54.
FerrucciLM, CartmelB, MolinaroAM.Indoor tanning and risk of early-onset basal cell carcinoma.J Am Acad Dermatol.2012; 67(4): 552–562.
55.
ZhangM, QureshiAA, GellerAC.Use of tanning beds and incidence of skin cancer.J Clin Oncol.2012; 30(14): 1588–1593.
56.
Canadian Skin Cancer Foundation.Skin Cancer Prevention.Edmonton, Canada: Canadian Skin Cancer Foundation;2012.
57.
Health Canada.Its Your Health.Ottawa, Canada: Health Canada;2011.
58.
World Health Organization.Individual Protection Against UV. Ultraviolet Radiation and the INTERSUN Programme. Geneva, Switzerland: World Health Organization;2013.
59.
Australian/New Zealand Standard AS/NZS 2635 (Solaria for cosmetic purposes).Sydney, Australia: Standards Australia and Standards New Zealand;2008.
CappugiP, MaviliaL, CampolmiP.New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.J Chemother.2004; 16(5): 491–493.
69.
AutierP, BoniolM, DoreJF.Sunscreen use and increased duration of intentional sun exposure: still a burning issue.Int J Cancer.2007; 121(1): 1–5.
70.
AutierP, DoreJF, NegrierS.Sunscreen use and duration of sun exposure: a double-blind, randomized trial.J Natl Cancer Inst.1999; 91(15): 1304–1309.
71.
AutierP, DoreJF, ReisAC.Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters.Br J Cancer.2000; 83(9): 1243–1248.
MenterJM, HatchKL.Clothing as solar radiation protection.Curr Probl Dermatol.2003; 31: 50–63.
76.
American Association of Textile Chemists and Colorists.AATCC Test Method 183-2010.Transmittance or Blocking of Erythemally Weighted Ultraviolet Radiation Through Fabrics.Research Triangle Park, NC: American Association of Textile Chemists and Colorists;1998.
77.
American Society for Testing and Materials.ASTM D6544-12 Standard Practice for Preparation of Textiles Prior to Ultraviolet (UV) Transmission Testing.West Conshohocken, PA: American Society for Testing and Materials;2012.
78.
American Society for Testing and Materials.ASTM D6603-12 Standard Specification for Labeling of UV-Protective Textiles.West Conshohocken, PA: American Society for Testing and Materials;2012.
PinnellSR, FairhurstD, GilliesR.Microfine zinc oxide is a superior sunscreen ingredient to microfine titanium dioxide.Dermatol Surg.2000; 26(4): 309–314.
82.
PinnellSR.Cutaneous photodamage, oxidative stress, and topical antioxidant protection.J Am Acad Dermatol.2003; 48(1): 1–19.
83.
US Food and Drug Administration.FDA Sheds Light on Sunscreens.Silver Spring, MD: US Food and Drug Administration;2012.
84.
Health Canada.Sunscreen Monograph.Ottawa, Canada: Health Products and Food Branch;2013.
85.
ThompsonSC, JolleyD, MarksR.Reduction of solar keratoses by regular sunscreen use.N Engl J Med.1993; 329(16): 1147–1151.
86.
PandeyaN, PurdieDM, GreenA, WilliamsG.Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial.Am J Epidemiol.2005; 161(8): 748–754.
87.
AutierP, BoniolM, SeveriG.Quantity of sunscreen used by European students.Br J Dermatol.2001; 144(2): 288–291.
88.
BimczokR, Gers-BarlagH, MundtC.Influence of applied quantity of sunscreen products on the sun protection factor—a multicenter study organized by the DGK Task Force Sun Protection.Skin Pharmacol Physiol.2007; 20(1): 57–64.
89.
FaurschouA, WulfHC.The relation between sun protection factor and amount of suncreen applied in vivo.Br J Dermatol.2007; 156(4): 716–719.
90.
AzurdiaRM, PagliaroJA, DiffeyBL, RhodesLE.Sunscreen application by photosensitive patients is inadequate for protection.Br J Dermatol.1999; 140(2): 255–258.
91.
YangHP, ChenK, JuM.A study of the way in which dermatologists and photosensitive patients apply sunscreen in China.Photodermatol Photoimmunol Photomed.2009; 25(5): 245–249.
92.
WrightMW, WrightST, WagnerRF.Mechanisms of sunscreen failure.J Am Acad Dermatol.2001; 44(5): 781–784.
93.
StokesRP, DiffeyBL.A novel ex vivo technique to assess the sand/rub resistance of sunscreen products.Int J Cosmet Sci.2000; 22(5): 329–334.
94.
BodekaerM, FaurschouA, PhilipsenPA, WulfHC.Sun protection factor persistence during a day with physical activity and bathing.Photodermatol Photoimmunol Photomed.2008; 24(6): 296–300.
95.
DiffeyBL.When should sunscreen be reapplied?J Am Acad Dermatol.2001; 45(6): 882–885.
96.
PruimB, WrightL, GreenA.Do people who apply sunscreens, re-apply them?Australas J Dermatol.1999; 40(2): 79–82.
97.
BullerDB, AndersenPA, WalkoszBJ.Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas.J Am Acad Dermatol.2012; 66(1): 63–70.
98.
NealeR, WilliamsG, GreenA.Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial.Arch Dermatol.2002; 138(10): 1319–1325.
99.
Ou-YangH, StanfieldJ, ColeC.High-SPF sunscreens (SPF >/= 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts.J Am Acad Dermatol.2012; 67(6): 1220–1227.
100.
RussakJE, ChenT, AppaY, RigelDS.A comparison of sunburn protection of high-sun protection factor (SPF) sunscreens: SPF 85 sunscreen is significantly more protective than SPF 50.J Am Acad Dermatol.2010; 62(2): 348–349.
101.
SapijaszkoM, ZlotyD, BourcierM.Non-melanoma skin cancer in Canada chapter 5: management of squamous cell carcinoma.J Cutan Med Surg.2015; 19: 249–259.
102.
ZlotyD, GuentherLC, SapijaszkoM.Non-melanoma skin cancer in Canada chapter 4: management of basal cell carcinoma.J Cutan Med Surg.2015; 19: 239–248.
103.
PoulinY, LyndeCW, BarberK.Non-melanoma skin cancer in Canada chapter 3: management of actinic keratoses.J Cutan Med Surg.2015; 19: 227–238.
104.
GuentherL, BarberK, SearlesGE.Non-melanoma skin cancer in Canada chapter 1: introduction to the guidelines.J Cutan Med Surg.2015; 19: 205–215.
